BiotechTube
Home/SixPeaks Bio/Estelle Marrer-Berger
EM

Estelle Marrer-Berger

SVP Non-Clinical & Translational Development

SixPeaks Bio

Therapeutic Areas

ObesityCardiometabolic Diseases

SixPeaks Bio Pipeline

DrugIndicationPhase
ActRIIA/B ProgramPreservation/expansion of skeletal muscle mass as companion to GLP-1 RAs for obesityPre-clinical

Leadership Team at SixPeaks Bio

PJ
Philip Just Larsen
Chief Executive Officer
KB
Konrad Bleicher
SVP Therapeutic Modalities
AP
Andreas Popp
SVP CMC
CM
Cornelia Maurer
Director Finance
View full SixPeaks Bio profile